dipyridamole has been researched along with Tachycardia, Paroxysmal in 2 studies
Dipyridamole: A phosphodiesterase inhibitor that blocks uptake and metabolism of adenosine by erythrocytes and vascular endothelial cells. Dipyridamole also potentiates the antiaggregating action of prostacyclin. (From AMA Drug Evaluations Annual, 1994, p752)
dipyridamole : A pyrimidopyrimidine that is 2,2',2'',2'''-(pyrimido[5,4-d]pyrimidine-2,6-diyldinitrilo)tetraethanol substituted by piperidin-1-yl groups at positions 4 and 8 respectively. A vasodilator agent, it inhibits the formation of blood clots.
Tachycardia, Paroxysmal: Abnormally rapid heartbeats with sudden onset and cessation.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Thormann, J | 1 |
| Schlepper, M | 1 |
| Neuss, H | 1 |
| Lindquist, JR | 1 |
| George, RP | 1 |
2 other studies available for dipyridamole and Tachycardia, Paroxysmal
| Article | Year |
|---|---|
Coronary hemodynamics in simulated paroxysms of ventricular tachycardia: role of myocardial impairment and of extravascular resistance.
Topics: Aorta; Aortic Valve Insufficiency; Blood Pressure; Coronary Circulation; Coronary Disease; Dipyridam | 1982 |
Thrombotic thrombocytopenic purpura: onset during dipyridamole therapy.
Topics: Blood Platelets; Dipyridamole; Female; Humans; Middle Aged; Purpura, Thrombotic Thrombocytopenic; Ta | 1981 |